Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Take A Stand for Workplace Health: A Sit-stand Workstation Project Evaluation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02172599
Recruitment Status : Completed
First Posted : June 24, 2014
Last Update Posted : January 18, 2018
Sponsor:
Collaborators:
Macmillan Canceer Support
Ergotron
Public Health England
Information provided by (Responsible Party):
Jennifer Hall, Brunel University

Brief Summary:
The purpose of this study is to examine the contribution of sit-stand workstations to total daily physical activity in a multi-component office-based 12 month intervention.

Condition or disease Intervention/treatment Phase
Physical Activity Behavioral: Sit-stand workstation provision Not Applicable

Detailed Description:
This study adopts a randomised control trial design and is mixed methods (qualitative and quantitative). The outcome data from the trial is quantitative. Alongside this a qualitative process evaluation will be conducted to inform the intervention, explain trial results and understand the intervention implementation and context (Cathain et al. 2014). Two worksites will participate in this study, in line with COCHRANE recommendations for randomised control trials.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial
Actual Study Start Date : May 2014
Actual Primary Completion Date : February 2016
Actual Study Completion Date : February 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: multi-component intervention

Sit-stand workstation provision

The multi-component intervention will align with the World Health Authority's promotion of a healthy workplace model, which emphasises that best-practice workplace health interventions should involve an integrated approach involving organisation and individual level approaches to behaviour change (WHO, 2010). Thus, participants will receive a sit-stand workstation with additional support to use the sit-stand workstation.

Behavioral: Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Other Name: Ergotron: workfit-A, workfit-D

Experimental: Sit-stand workstation only

Sit-stand workstation provision

Participants in this arm will receive a sit-stand workstation. They will not receive any support to use the sit-stand workstation, except some health and safety advice upon installation.

Behavioral: Sit-stand workstation provision
The research compares the effects of a sit-stand workstation only and a multi-component sit-stand workstation intervention including individual and organisation-level approaches, with usual office-based working practice (no sit-stand workstation) over 12 months.
Other Name: Ergotron: workfit-A, workfit-D

No Intervention: Usual practice (seated workstation)
This arm is the control group. They will continue to use their usual seated workstation for the duration of the study.



Primary Outcome Measures :
  1. Physical Activity [ Time Frame: Measured 5 times over 13 months, for seven days each time. Time points = baseline, 1-2weeks, 3 months, 6 months and 12 months ]

    ActivPAL:

    Sitting and standing will be measured objectively using the ActivPAL device. The ActivPAL provides reliable measures of total sitting time and standing time, and number of sit-to-stand transitions per hour (Lyden et al. 2012).

    ActiGraph (GT3X+):

    Physical activity intensity and duration will be measured objectively using the ActiGraph activity monitor.The GT3X reliably classifies physical activity intensity in free-living environments (Ozemek et al. 2014).

    Activity diaries:

    These dairies will be used to assess the type and context of physical activity behaviour. A text reminder will be sent to all participants once daily for the duration of the data collection period. Text message models have shown some success in increasing compliance to research (Armstrong et al. 2009).




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
  • Must engage in primarily desk-based work
  • Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
  • Must have no plans to leave the organisation for an extended period (e.g. holiday > 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

  • Have engaged in standing-based desk work in the month prior to the start of the study
  • Have been advised against standing by a health professional; or be unable to stand
  • Work for the Macmillan Support Line

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02172599


Locations
Layout table for location information
United Kingdom
Public Health England, SKipton House
London, United Kingdom, SE1 6LH
Macmillan Cancer Support UK Office
London, United Kingdom, SE1 7UQ
Sponsors and Collaborators
Brunel University
Macmillan Canceer Support
Ergotron
Public Health England
Investigators
Layout table for investigator information
Principal Investigator: Jennifer Hall, BSc Brunel University
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Jennifer Hall, PhD Researcher, Brunel University
ClinicalTrials.gov Identifier: NCT02172599    
Other Study ID Numbers: TSWH
R33134 ( Other Grant/Funding Number: Macmillan Cancer Support )
First Posted: June 24, 2014    Key Record Dates
Last Update Posted: January 18, 2018
Last Verified: January 2018
Keywords provided by Jennifer Hall, Brunel University:
sit-stand workstation
workplace
multi-component intervention
randomised control trial design
physical activity
sitting
sedentary behaviour
process evaluation
health